The Crohn’s & Colitis Foundation provides a growing selection of professional events and clinical education designed to advance your care for patients living with inflammatory bowel disease (IBD).
To view the agenda, please click here.
Rawlins Campbell, PharmD University of Florida Health |
Co-Chair, IBD Pro Jami Kinnucan, MD Mayo Clinic |
Jacqueline Larson, MD University of South Florida Health |
Co-Chair, MyIBD Learning Angela Pham, MD University of Florida Health |
Co-Chair, IBD Pro Siobhan Proksell, MD University of Miami Health |
Megan Riehl, PsyD University of Michigan Health |
Co-Chair, MyIBD Learning Jennifer Seminerio, MD University of South Florida |
Krista Terracina, MD University of Florida Health |
|
Hotel Accommodation
To book a hotel room at the Hyatt Place/Hyatt House Tampa Downtown with our special discounted rate, click here.
Conference Venue & Parking
Directions to USF CAMLS, maps, and parking info can be found on the CAMLS website here and on a two-page PDF here.
Conference Check-In
Registration begins at 9:00 a.m. and ends at 9:30 a.m. ET.
Refreshments
A light breakfast will be available during the check-in period, and a buffet-style lunch will be served during the lunch break. If you have specific dietary needs, you are welcome to bring your own food/beverage to the venue.
COVID-19 Related Safety Protocols
- Masks are recommended but not required.
- Please practice social distancing whenever possible.
Picture/Video Disclaimer
Photographs and/or video may be taken at this program. By attending this program, you grant full permission to the Crohn’s & Colitis Foundation for the free use of your picture and voice in any broadcast, telecast, print account or any other account in any medium of this event, and acknowledge that the Crohn’s & Colitis Foundation does hereby have the unrestrained right in perpetuity to own, utilize, or alter any such pictures or video of me, in any manner it may see fit and for any purpose whatsoever.
Request for Credit
A maximum of 4.0 AMA PRA Category 1 Credits will be available. In order to obtain your CME/CE certificate, please complete the Accredited CE Activity Evaluation form at the conclusion of the activity, and return it to Anthony Campo, Senior Manager of Education & Engagement, at [email protected].
Target Audience
This activity is intended for physicians (MD/DO/PA/NP) and registered nurses involved in the care of patients with inflammatory bowel disease. CME credits are available to physicians, while a Certificate of Accredited Continuing Education will be available for nurses.
Learning Objectives
- Coming Soon!
Disclosure of Conflicts of Interest
SAPS CME as the Accredited Continuing Education (ACE) provider must ensure that this activity and the presentations are in full compliance with The Accreditation Council for Continuing Medical Education (ACCME) guidelines. It is important to assure the public that education received by physicians and other health care professionals who determine patient care decisions with the highest integrity, scientific objectivity. A conflict of interest (COI) exists when individuals have both a financial relationship with an ineligible company (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients) and the opportunity to affect the content of accredited CE about the product or services of that ineligible company.
SAPS CME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of Georgia through the joint providership of Southern Alliance for Physician Specialties CME and Crohn's & Colitis Foundation. The Southern Alliance for Physician Specialties CME is accredited by the Medical Association of Georgia to provide accredited continuing education for physicians. The Southern Alliance for Physician Specialties CME designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Fee Statement
Physician: $60
Allied Health/Nursing/Pharmacist: $25
Fellow/Trainee/Student: Free
Naueen Chaudhry, MD University of Florida Health |
Susan Kais, MD Advent Health |
Co-Chair, IBD Pro Jami Kinnucan, MD Mayo Clinic |
Lauren Loeb, MD Mayo Clinic |
Co-Chair, MyIBD Learning Angela Pham, MD University of Florida Health |
Co-Chair, IBD Pro Siobhan Proksell, MD University of Miami Health |
|
Co-Chair, MyIBD Learning Jennifer Seminerio, MD University of South Florida |
Krista Terracina, MD University of Florida Health |
|
For more information, please contact Anthony Campo, Senior Manager of Education & Engagement, at [email protected].
This activity is supported by:
| AbbVie | Johnson & Johnson | Takeda |
For more information on MyIBD Learning: Tampa Bay -- our patient and caregiver education conference also taking place on June 8, 2024 -- click here.